Republican lawmakers are examining OpenAI CEO Sam Altman’s personal investment portfolio, a move that threatens to slow the artificial intelligence company’s planned initial public offering. The scrutiny, which has not been publicly detailed, could force OpenAI to push back its timeline for going public, according to people familiar with the matter.
Why the GOP is looking at Altman’s holdings
The investigation focuses on whether Altman’s outside investments create conflicts of interest with OpenAI’s business. Lawmakers have not disclosed which specific investments are under review or how far back the probe reaches. The company declined to comment on the record, and Altman’s representatives did not respond to requests for comment.
What an IPO delay would mean for OpenAI
OpenAI has been laying groundwork for an IPO for months, hiring underwriters and preparing financial disclosures. A delay would disrupt those plans and could affect the valuation the company hopes to command. The company has not set a firm IPO date, but insiders had expected a filing within the next year.
The GOP probe adds an unpredictable variable. Even if the review finds no violations, the time and attention required to respond could push back the IPO timeline by weeks or longer. Investors are watching closely, but no one has publicly pulled out of discussions to buy shares.
What happens next
The congressional review is still in its early stages. No hearings have been scheduled, and no subpoenas have been issued. OpenAI and Altman are likely to face questions about the investments in writing before any public session takes place.
The company has not said whether it will delay its IPO voluntarily while the probe runs its course. A spokesperson for the relevant committee did not return a call seeking comment. For now, the clock is ticking on both the investigation and OpenAI’s market debut.
